CORD-19:48b81081bbcbdbea648394d8bf2adf370b36e44c / 244994-245082
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T20137","span":{"begin":0,"end":88},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Primary efficacy endpoint is change from baseline to year 1 in HADS depressive symptoms."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T10","span":{"begin":0,"end":88},"obj":"Sentence"}],"text":"Primary efficacy endpoint is change from baseline to year 1 in HADS depressive symptoms."}